206 related articles for article (PubMed ID: 22893706)
1. Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.
Li J; Mo HY; Xiong G; Zhang L; He J; Huang ZF; Liu ZW; Chen QY; Du ZM; Zheng LM; Qian CN; Zeng YX
J Biol Chem; 2012 Oct; 287(42):35484-35495. PubMed ID: 22893706
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
[TBL] [Abstract][Full Text] [Related]
3. The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma.
Zhang L; Ye SB; Ma G; Tang XF; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
J Transl Med; 2013 Mar; 11():60. PubMed ID: 23497377
[TBL] [Abstract][Full Text] [Related]
4. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
[TBL] [Abstract][Full Text] [Related]
5. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells.
Stojanović I; Cvjetićanin T; Lazaroski S; Stosić-Grujicić S; Miljković D
Immunology; 2009 Jan; 126(1):74-83. PubMed ID: 18624729
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
[TBL] [Abstract][Full Text] [Related]
8. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection.
Trifone C; Baquero L; Czernikier A; Benencio P; Leng L; Laufer N; Quiroga MF; Bucala R; Ghiglione Y; Turk G
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298774
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma.
Liao B; Zhong BL; Li Z; Tian XY; Li Y; Li B
J Surg Oncol; 2010 Dec; 102(7):844-51. PubMed ID: 20872800
[TBL] [Abstract][Full Text] [Related]
11. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
[TBL] [Abstract][Full Text] [Related]
12. Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
García-Arellano S; Hernández-Palma LA; Bucala R; Hernández-Bello J; De la Cruz-Mosso U; García-Iglesias T; Cerpa-Cruz S; Padilla-Gutiérrez JR; Valle Y; Soñanez-Organis JG; Parra-Rojas I; Pereira-Suárez AL; Muñoz-Valle JF
Curr Mol Med; 2018; 18(10):679-688. PubMed ID: 30698113
[TBL] [Abstract][Full Text] [Related]
13. [Effect of macrophage migration inhibitory factor (MIF) on expression of MMP-2,MMP-9,and IL-8 in nasopharyngeal carcinoma cell strains].
Li Z; Lin SX; Liang YJ; Zong YS
Ai Zheng; 2004 Feb; 23(2):130-5. PubMed ID: 14960229
[TBL] [Abstract][Full Text] [Related]
14. The presence of tumor-infiltrating IL-17-producing cells in juvenile nasopharyngeal angiofibroma tumor microenvironment is a poor prognostic factor.
Sun X; Guo L; Wang H; Yu H; Wang J; Meng X; Liu Z; Liu J; Hu L; Li H; Wang D
Am J Otolaryngol; 2014; 35(5):582-8. PubMed ID: 25014998
[TBL] [Abstract][Full Text] [Related]
15. Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma.
Li J; Huang ZF; Xiong G; Mo HY; Qiu F; Mai HQ; Chen QY; He J; Chen SP; Zheng LM; Qian CN; Zeng YX
J Transl Med; 2011 Nov; 9():189. PubMed ID: 22051182
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
17. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.
Xue H; Yang Y; Zhang Y; Song S; Zhang L; Ma L; Yang T; Liu H
Mediators Inflamm; 2015; 2015():621072. PubMed ID: 25861163
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Subbannayya T; Leal-Rojas P; Barbhuiya MA; Raja R; Renuse S; Sathe G; Pinto SM; Syed N; Nanjappa V; Patil AH; Garcia P; Sahasrabuddhe NA; Nair B; Guerrero-Preston R; Navani S; Tiwari PK; Santosh V; Sidransky D; Prasad TS; Gowda H; Roa JC; Pandey A; Chatterjee A
BMC Cancer; 2015 Nov; 15():843. PubMed ID: 26530123
[TBL] [Abstract][Full Text] [Related]
20. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Hernández-Palma LA; García-Arellano S; Bucala R; Llamas-Covarrubias MA; De la Cruz-Mosso U; Oregon-Romero E; Cerpa-Cruz S; Parra-Rojas I; Plascencia-Hernández A; Muñoz-Valle JF
Cytokine; 2019 Mar; 115():89-96. PubMed ID: 30467094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
